Greenwich LifeSciences, Inc.
GLSI· Nasdaq
Released Apr 15, 2025, after the close
10-K filed Apr 15, 2025, 105 days after period end · 0001641172-25-004819
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$9.67M | -$2.75M | -$2.79M | -$2.36M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Greenwich LifeSciences, Inc. · CIK 1799788 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Dec 31, 2024 · filed Apr 15, 2025 · 105 d after period end
1.2% from the close of Apr 15, 2025 to the close of Apr 16, 2025, the first after the release.